PAPER Nagori K, Pradhan M, Sharma M, Ajazuddin, Badwaik HR, Nakhate KT
SEARCH RESULTS
329750 RESULTS
PAPER O'Leary TP, Brown RE
Age-related changes in species-typical behaviours in the 5xFAD mouse model of Alzheimer's disease from 4-16 months of age.
Behav Brain Res. 2024 Mar 24;:114970. PubMed: 38531510PAPER Isaev NK, Genrikhs EE, Stelmashook EV
Methylene blue and its potential in the treatment of traumatic brain injury, brain ischemia, and Alzheimer's disease.
Rev Neurosci. 2024 Mar 27; PubMed: 38530227PAPER Lee AT, Luo Y, Huo Z, Shi L, Chu WC, Lam LC
Effect of increasing cognitive activity participation on default mode network in older adults with subjective cognitive decline: a randomised controlled trial.
EBioMedicine. 2024 Mar 25;102:105082. PubMed: 38531174PAPER Sun Y, Zhang L, Ye H, Leng L, Chen Y, Su Y, Ren P, Lu H, Peng G
Potential ocular indicators to distinguish posterior cortical atrophy and typical Alzheimer's disease: a cross-section study using optical coherence tomography angiography.
Alzheimers Res Ther. 2024 Mar 25;16(1):64. PubMed: 38528626PAPER Yu B, Wan G, Cheng S, Wen P, Yang X, Li J, Tian H, Gao Y, Zhong Q, Liu J, Li J, Zhu Y
Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study.
Curr Alzheimer Res. 2024 Mar 25; PubMed: 38529601PAPER Morales-Prieto N, Bevans R, O'Mahony A, Barron A, Giles Doran C, McCarthy E, Concannon RM, Goulding SR, McCarthy CM, Collins LM, Sullivan AM, O'Keeffe GW
Human α-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing.
Aging Cell. 2024 Mar 26;:e14155. PubMed: 38529808PAPER Cai H, Pang Y, Ren Z, Fu X, Jia L
Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
BMC Med. 2024 Mar 25;22(1):138. PubMed: 38528511PAPER Hartmann J, Bajaj T, Otten J, Klengel C, Ebert T, Gellner AK, Junglas E, Hafner K, Anderzhanova EA, Tang F, Missig G, Rexrode L, Trussell DT, Li KX, Pöhlmann ML, Mackert S, Geiger TM, Heinz DE, Lardenoije R, Dedic N, McCullough KM, Próchnicki T, Rhomberg T, Martinelli S, Payton A, Robinson AC, Stein V, Latz E, Carlezon WA Jr, Hausch F, Schmidt MV, Murgatroyd C, Berretta S, Klengel T, Pantazopoulos H, Ressler KJ, Gassen NC
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration.
Nat Commun. 2024 Mar 25;15(1):2635. PubMed: 38528004PAPER Oliveira NA, Pinho BR, Pinto J, de Pinho PG, Oliveira JM
Edaravone counteracts redox and metabolic disruptions in an emerging zebrafish model of sporadic ALS.
Free Radic Biol Med. 2024 Mar 24; PubMed: 38531462PAPER Das V, Miller JH, Alladi CG, Annadurai N, De Sanctis JB, Hrubá L, Hajdúch M
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies.
Med Res Rev. 2024 Mar 26; PubMed: 38530106PAPER Li W, Li JY
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration.
Transl Neurodegener. 2024 Mar 26;13(1):16. PubMed: 38528629PAPER Laferrière F, Sabatier L, Claverol S, De Giorgi F, Ichas F
Biases in α-synuclein immuno-quantitation: a core problem for basic and ancillary studies of Parkinson's disease and multiple system atrophy.
Transl Neurodegener. 2024 Mar 25;13(1):15. PubMed: 38528639PAPER Wang J, Gleeson PA, Fourriere L
Spatial-Temporal Mapping Reveals the Golgi as the Major Processing Site for the Pathogenic Swedish APP Mutation: Familial APP Mutant Shifts the Major APP Processing Site.
Traffic. 2024 Mar;25(3):e12932. PubMed: 38528836PAPER Wißfeld J, Abou Assale T, Cuevas-Rios G, Liao H, Neumann H
Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.
Front Neurol. 2024;15:1330874. Epub 2024 Mar 11 PubMed: 38529039Current Filters
- Date Range : All x